Candriam S.C.A. Qiagen N.V. Call Options Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding QGEN
# of Institutions
22Shares Held
6.37MCall Options Held
0Put Options Held
0-
Pendal Group LTD4.3MShares$181 Million1.76% of portfolio
-
Abeille Asset Management Sa931KShares$39.2 Million1.68% of portfolio
-
Grandeur Peak Global Advisors, LLC Salt Lake City, UT796KShares$33.5 Million3.21% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8153KShares$6.46 Million0.01% of portfolio
-
Bdl Capital Management Paris, I088.8KShares$3.74 Million3.33% of portfolio
About QIAGEN N.V.
- Ticker QGEN
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 227,694,000
- Market Cap $9.58B
- Description
- QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...